Nanoparticle Platforms for Antigen-Specific Immune Tolerance

Innovative approaches in nanoparticle design have facilitated the creation of new formulations of nanoparticles that are capable of selectively calibrating the immune response. These nanomaterials may be engineered to interact with specific cellular and molecular targets. Recent advancements in nano...

Full description

Bibliographic Details
Main Authors: Edward B. Thorp, Christian Boada, Clarens Jarbath, Xunrong Luo
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-05-01
Series:Frontiers in Immunology
Subjects:
Online Access:https://www.frontiersin.org/article/10.3389/fimmu.2020.00945/full
id doaj-238953b5a51943bdbfd0faf645702f7b
record_format Article
spelling doaj-238953b5a51943bdbfd0faf645702f7b2020-11-25T03:22:08ZengFrontiers Media S.A.Frontiers in Immunology1664-32242020-05-011110.3389/fimmu.2020.00945529959Nanoparticle Platforms for Antigen-Specific Immune ToleranceEdward B. Thorp0Christian Boada1Clarens Jarbath2Xunrong Luo3Xunrong Luo4Departments of Pathology & Pediatrics at Northwestern University Feinberg School of Medicine, Chicago, IL, United StatesDivision of Nephrology, Department of Medicine, Duke University School of Medicine, Durham, NC, United StatesDepartments of Pathology & Pediatrics at Northwestern University Feinberg School of Medicine, Chicago, IL, United StatesDivision of Nephrology, Department of Medicine, Duke University School of Medicine, Durham, NC, United StatesDuke Transplant Center, Duke University School of Medicine, Durham, NC, United StatesInnovative approaches in nanoparticle design have facilitated the creation of new formulations of nanoparticles that are capable of selectively calibrating the immune response. These nanomaterials may be engineered to interact with specific cellular and molecular targets. Recent advancements in nanoparticle synthesis have enabled surface functionalization of particles that mimic the diversity of ligands on the cell surface. Platforms synthesized using these design principles, called “biomimetic” nanoparticles, have achieved increasingly sophisticated targeting specificity and cellular trafficking capabilities. This holds great promise for next generation therapies that seek to achieve immune tolerance. In this review, we discuss the importance of physical design parameters including size, shape, and biomimetic surface functionalization, on the biodistribution, safety and efficacy of biologic nanoparticles. We will also explore potential applications for immune tolerance for organ or stem cell transplantation.https://www.frontiersin.org/article/10.3389/fimmu.2020.00945/fullnanoparticlestolerancetransplantrejectionimmunity
collection DOAJ
language English
format Article
sources DOAJ
author Edward B. Thorp
Christian Boada
Clarens Jarbath
Xunrong Luo
Xunrong Luo
spellingShingle Edward B. Thorp
Christian Boada
Clarens Jarbath
Xunrong Luo
Xunrong Luo
Nanoparticle Platforms for Antigen-Specific Immune Tolerance
Frontiers in Immunology
nanoparticles
tolerance
transplant
rejection
immunity
author_facet Edward B. Thorp
Christian Boada
Clarens Jarbath
Xunrong Luo
Xunrong Luo
author_sort Edward B. Thorp
title Nanoparticle Platforms for Antigen-Specific Immune Tolerance
title_short Nanoparticle Platforms for Antigen-Specific Immune Tolerance
title_full Nanoparticle Platforms for Antigen-Specific Immune Tolerance
title_fullStr Nanoparticle Platforms for Antigen-Specific Immune Tolerance
title_full_unstemmed Nanoparticle Platforms for Antigen-Specific Immune Tolerance
title_sort nanoparticle platforms for antigen-specific immune tolerance
publisher Frontiers Media S.A.
series Frontiers in Immunology
issn 1664-3224
publishDate 2020-05-01
description Innovative approaches in nanoparticle design have facilitated the creation of new formulations of nanoparticles that are capable of selectively calibrating the immune response. These nanomaterials may be engineered to interact with specific cellular and molecular targets. Recent advancements in nanoparticle synthesis have enabled surface functionalization of particles that mimic the diversity of ligands on the cell surface. Platforms synthesized using these design principles, called “biomimetic” nanoparticles, have achieved increasingly sophisticated targeting specificity and cellular trafficking capabilities. This holds great promise for next generation therapies that seek to achieve immune tolerance. In this review, we discuss the importance of physical design parameters including size, shape, and biomimetic surface functionalization, on the biodistribution, safety and efficacy of biologic nanoparticles. We will also explore potential applications for immune tolerance for organ or stem cell transplantation.
topic nanoparticles
tolerance
transplant
rejection
immunity
url https://www.frontiersin.org/article/10.3389/fimmu.2020.00945/full
work_keys_str_mv AT edwardbthorp nanoparticleplatformsforantigenspecificimmunetolerance
AT christianboada nanoparticleplatformsforantigenspecificimmunetolerance
AT clarensjarbath nanoparticleplatformsforantigenspecificimmunetolerance
AT xunrongluo nanoparticleplatformsforantigenspecificimmunetolerance
AT xunrongluo nanoparticleplatformsforantigenspecificimmunetolerance
_version_ 1724611007399067648